| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $114,341 | 3 | 23 |
Sells | $41,335 | 10 | 77 |
| Blume-Jensen Peter | President and CEO | 1 | $82,124 | 2 | $34,412 | $47,712 |
| Devroe Eric | Chief Operating Officer | 1 | $17,218 | 1 | $1,214 | $16,004 |
| Levy Adam D. | Chief Financial Officer | 1 | $14,999 | 1 | $1,793 | $13,206 |
| Peterson Katharine | Chief Accounting Officer | 0 | $0 | 1 | $203 | $-203 |
| Gamelin Erick | Chief Development Officer | 0 | $0 | 1 | $804 | $-804 |
| Miller Mary | Chief Legal Officer | 0 | $0 | 4 | $2,909 | $-2,909 |
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are …
Over the last 12 months, insiders at Acrivon Therapeutics, Inc. Common Stock have bought $114,341 and sold $41,335 worth of Acrivon Therapeutics, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Acrivon Therapeutics, Inc. Common Stock have bought $22.49M and sold $1.3M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Blume-Jensen Peter (President and CEO) — $82,124. Devroe Eric (Chief Operating Officer) — $17,218. Levy Adam D. (Chief Financial Officer) — $14,999.
The last purchase of 49,000 shares for transaction amount of $82,124 was made by Blume-Jensen Peter (President and CEO) on 2026‑01‑14.
| 2026-10-22 | Sale | Miller Mary | Chief Legal Officer | 513 0.0013% | $1.84 | $944 | -1.99% | |
| 2026-10-05 | Sale | Miller Mary | Chief Legal Officer | 294 0.0007% | $1.99 | $585 | -11.11% | |
| 2026-08-25 | Sale | Blume-Jensen Peter | President and CEO | 14,036 0.0332% | $2.21 | $30,969 | -12.39% | |
| 2026-08-18 | Sale | Blume-Jensen Peter | President and CEO | 1,713 0.0039% | $2.01 | $3,443 | -3.17% | |
| 2026-08-18 | Sale | Devroe Eric | Chief Operating Officer | 604 0.0014% | $2.01 | $1,214 | -3.17% | |
| 2026-08-18 | Sale | Miller Mary | Chief Legal Officer | 185 0.0004% | $2.01 | $372 | -3.17% | |
| 2026-08-18 | Sale | Gamelin Erick | Chief Development Officer | 400 0.0009% | $2.01 | $804 | -3.17% | |
| 2026-08-18 | Sale | Peterson Katharine | Chief Accounting Officer | 101 0.0002% | $2.01 | $203 | -3.17% | |
| 2026-08-04 | Sale | Levy Adam D. | Chief Financial Officer | 1,142 0.0027% | $1.57 | $1,793 | +23.72% | |
| 2026-07-21 | Sale | Miller Mary | Chief Legal Officer | 573 0.0018% | $1.76 | $1,008 | +6.00% | |
| 2026-01-14 | Blume-Jensen Peter | President and CEO | 49,000 0.1422% | $1.68 | $82,124 | -5.19% | ||
| 2026-01-14 | Levy Adam D. | Chief Financial Officer | 8,832 0.026% | $1.70 | $14,999 | -5.19% | ||
| 2026-01-13 | Devroe Eric | Chief Operating Officer | 10,000 0.0321% | $1.72 | $17,218 | +2.35% | ||
| 2025-05-01 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 298,886 0.9604% | $1.34 | $400,507 | +21.05% | |
| 2025-04-30 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 437,881 1.4067% | $1.41 | $617,412 | +15.00% | |
| 2025-04-29 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 250,000 0.7808% | $1.41 | $352,500 | +11.11% | |
| 2025-04-28 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 215,283 0.6532% | $1.56 | $335,841 | +3.23% | |
| 2025-04-25 | Sale | PERCEPTIVE ADVISORS LLC | 10 percent owner | 1.05M 3.9999% | $1.95 | $2.06M | -2.44% | |
| 2024-04-11 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 2.35M 8.4743% | $8.50 | $20M | -22.39% | ||
| 2023-06-26 | Sale | Chione Ltd | 10 percent owner | 16 <0.0001% | $12.93 | $207 | -48.66% |
| Blume-Jensen Peter | President and CEO | 2230052 5.2039% | $3.72M | 1 | 2 | |
| Devroe Eric | Chief Operating Officer | 146349 0.3415% | $244,402.83 | 1 | 1 | |
| Levy Adam D. | Chief Financial Officer | 66008 0.154% | $110,233.36 | 1 | 1 | |
| RA CAPITAL MANAGEMENT, L.P. | 4384206 10.2307% | $7.32M | 1 | 0 | <0.0001% | |
| Chione Ltd | 10 percent owner | 3848632 8.9809% | $6.43M | 1 | 5 | <0.0001% |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 3104139 7.2436% | $5.18M | 1 | 5 | <0.0001% |
$5,831,763 | 118 | -33.78% | $66.68M | |
$9,405,928 | 107 | 12.61% | $74.85M | |
$17,525,882 | 60 | 5.22% | $64.7M | |
$19,705,388 | 47 | 86.26% | $67.15M | |
$909,129 | 37 | 42.19% | $67.23M |
| Increased Positions | 24 | +50% | 2M | +10.54% |
| Decreased Positions | 17 | -35.42% | 713,771 | -4.08% |
| New Positions | 8 | New | 136,860 | New |
| Sold Out Positions | 7 | Sold Out | 80,737 | Sold Out |
| Total Postitions | 55 | +14.58% | 19M | +6.46% |
| Ra Capital Management, L.P. | $20,518.00 | 26.06% | 8.34M | 0 | 0% | 2025-09-30 |
| Sands Capital Alternatives, Llc | $5,222.00 | 6.63% | 2.12M | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $3,792.00 | 4.82% | 1.54M | -354,193 | -18.69% | 2025-09-30 |
| Wellington Management Group Llp | $2,185.00 | 2.78% | 888,130 | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $1,681.00 | 2.13% | 683,218 | +682,763 | +150,057.8% | 2025-09-30 |
| Vanguard Group Inc | $1,540.00 | 1.96% | 626,148 | +32,901 | +5.55% | 2025-09-30 |
| Renaissance Technologies Llc | $1,534.00 | 1.95% | 623,400 | +114,105 | +22.41% | 2025-09-30 |
| Acorn Capital Advisors, Llc | $997.00 | 1.27% | 405,237 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $814.00 | 1.03% | 330,957 | -76,665 | -18.81% | 2025-09-30 |
| Two Sigma Investments, Lp | $785.00 | 1% | 319,205 | +138,033 | +76.19% | 2025-09-30 |